Evidence map›Paper›PMID 32198722›Full record

Observational studyInternal and emergency medicine2020

Efficacy of a new nutraceutical formulation (CHETOGERD

Giulia Fiorini, Ilaria Maria Saracino, Matteo Pavoni, Laura Saccomanno, Dino Vaira

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Internal and emergency medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Giulia FioriniDepartment of Surgical and Medical Sciences, Sant'Orsola Hospital, University of Bologna, Bologna, Italy.
Ilaria Maria SaracinoDepartment of Surgical and Medical Sciences, Sant'Orsola Hospital, University of Bologna, Bologna, Italy.
Matteo PavoniDepartment of Surgical and Medical Sciences, Sant'Orsola Hospital, University of Bologna, Bologna, Italy.
Laura SaccomannoDepartment of Surgical and Medical Sciences, Sant'Orsola Hospital, University of Bologna, Bologna, Italy.
Dino VairaDepartment of Surgical and Medical Sciences, Sant'Orsola Hospital, University of Bologna, Bologna, Italy. berardino.vaira@unibo.it.
University of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonerosive reflux disease (NERD) is a gastrointestinal disorder that leads to symptoms such as heartburn and regurgitation without visible esophageal mucosal injury, and it is treated with proton-pump inhibitors (PPIs). CHETOGERD

Indexed as

Dietary SupplementsFemaleGastroesophageal RefluxHumansMaleMiddle AgedProspective StudiesSurveys and QuestionnairesChetogerdCHETOGERD®NERDNutraceuticalsReflux disease

Identifiers

PMID32198722
OpenAlexW3011290448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.